TATVASpecialty Chemicals
Tatva Chintan Pharma Chem Limited — Balance Sheet
₹1052.40
-5.07%
Tatva Chintan Pharma Chem Limited Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.34 Cr | 2.34 Cr | 2.22 Cr | 2.22 Cr | — |
| Share Issued | 2.34 Cr | 2.34 Cr | 2.22 Cr | 2.22 Cr | — |
| Net Debt | 25.01 Cr | — | 142.89 Cr | 56.92 Cr | 85.77 Cr |
| Total Debt | 36.39 Cr | 14.27 Cr | 170.26 Cr | 119.94 Cr | — |
| Tangible Book Value | 732.92 Cr | 733.12 Cr | 514.32 Cr | 472.77 Cr | — |
| Invested Capital | 775.21 Cr | 751.35 Cr | 685.05 Cr | 593.03 Cr | — |
| Working Capital | 169.22 Cr | 218.24 Cr | 73.56 Cr | 264.44 Cr | — |
| Net Tangible Assets | 732.92 Cr | 733.12 Cr | 514.32 Cr | 472.77 Cr | — |
| Common Stock Equity | 738.82 Cr | 737.08 Cr | 514.79 Cr | 473.09 Cr | — |
| Total Capitalization | 738.82 Cr | 737.72 Cr | 519.02 Cr | 486.20 Cr | — |
| Total Equity Gross Minority Interest | 738.82 Cr | 737.08 Cr | 514.79 Cr | 473.09 Cr | — |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Stockholders Equity | 738.82 Cr | 737.08 Cr | 514.79 Cr | 473.09 Cr | — |
| Other Equity Interest | 715.43 Cr | 713.69 Cr | 492.63 Cr | 450.92 Cr | — |
| Capital Stock | 23.39 Cr | 23.39 Cr | 22.16 Cr | 22.16 Cr | — |
| Common Stock | 23.39 Cr | 23.39 Cr | 22.16 Cr | 22.16 Cr | — |
| Total Liabilities Net Minority Interest | 97.42 Cr | 81.64 Cr | 244.07 Cr | 184.97 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 1.40 Cr | 1.97 Cr | 5.38 Cr | 13.77 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.64 Cr | 4.23 Cr | 13.11 Cr | — |
| Long Term Debt | 0.00 | 0.64 Cr | 4.23 Cr | 13.11 Cr | — |
| Long Term Provisions | 1.40 Cr | 1.33 Cr | 1.15 Cr | 0.65 Cr | — |
| Current Liabilities | 96.03 Cr | 79.66 Cr | 238.69 Cr | 171.20 Cr | — |
| Other Current Liabilities | 19.04 Cr | 12.32 Cr | 7.67 Cr | 18.54 Cr | — |
| Current Deferred Taxes Liabilities | 2.02 Cr | 0.08 Cr | 0.21 Cr | 1.02 Cr | — |
| Current Debt And Capital Lease Obligation | 36.39 Cr | 13.63 Cr | 166.03 Cr | 106.83 Cr | — |
| Current Debt | 36.39 Cr | 13.63 Cr | 166.03 Cr | 106.83 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 0.42 Cr | 0.36 Cr | 0.33 Cr | 0.18 Cr | — |
| Payables | 32.69 Cr | 61.75 Cr | 68.01 Cr | 61.05 Cr | — |
| Accounts Payable | 32.69 Cr | 45.03 Cr | 32.19 Cr | 44.51 Cr | — |
| Total Assets | 836.25 Cr | 818.72 Cr | 758.86 Cr | 658.05 Cr | — |
| Total Non Current Assets | 571.00 Cr | 520.81 Cr | 446.61 Cr | 222.42 Cr | — |
| Other Non Current Assets | 1.11 Cr | 0.83 Cr | 0.55 Cr | 0.51 Cr | — |
| Non Current Deferred Taxes Assets | 12.62 Cr | 12.30 Cr | 16.40 Cr | 8.71 Cr | — |
| Investmentin Financial Assets | 4.28 Cr | 4.26 Cr | 2.85 Cr | 2.09 Cr | — |
| Available For Sale Securities | 4.28 Cr | 4.26 Cr | 2.85 Cr | 2.09 Cr | — |
| Goodwill And Other Intangible Assets | 5.90 Cr | 3.96 Cr | 0.48 Cr | 0.32 Cr | — |
| Other Intangible Assets | 5.90 Cr | 3.96 Cr | 0.48 Cr | 0.32 Cr | — |
| Net PPE | 547.09 Cr | 499.46 Cr | 426.51 Cr | 210.79 Cr | — |
| Gross PPE | 547.09 Cr | 559.90 Cr | 461.57 Cr | 236.99 Cr | — |
| Construction In Progress | 21.54 Cr | 72.93 Cr | 230.74 Cr | 51.49 Cr | — |
| Other Properties | 525.55 Cr | 46.21 Cr | 16.90 Cr | 11.59 Cr | — |
| Current Assets | 265.25 Cr | 297.91 Cr | 312.25 Cr | 435.64 Cr | — |
| Other Current Assets | 26.36 Cr | 0.70 Cr | 0.59 Cr | 0.42 Cr | — |
| Prepaid Assets | 6.97 Cr | 23.32 Cr | 15.89 Cr | 26.85 Cr | — |
| Inventory | 133.95 Cr | 152.77 Cr | 162.50 Cr | 169.96 Cr | — |
| Other Receivables | 0.24 Cr | 2.93 Cr | 3.59 Cr | 4.71 Cr | — |
| Accounts Receivable | 82.53 Cr | 69.85 Cr | 84.40 Cr | 56.60 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 15.20 Cr | 45.67 Cr | 41.22 Cr | 63.82 Cr | — |
| Other Short Term Investments | 3.82 Cr | 10.36 Cr | 13.85 Cr | 0.80 Cr | — |
| Cash And Cash Equivalents | 11.37 Cr | 35.30 Cr | 27.36 Cr | 63.02 Cr | — |
| Retained Earnings | — | 307.71 Cr | 282.20 Cr | 241.47 Cr | 145.60 Cr |
| Additional Paid In Capital | — | 404.39 Cr | 209.03 Cr | 209.03 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 1.33 Cr | 1.15 Cr | 0.65 Cr | 0.55 Cr |
| Other Payable | — | 16.72 Cr | 35.82 Cr | 16.53 Cr | 5.60 Cr |
| Dividends Payable | — | 20000.00 | 10000.00 | 0.00 | — |
| Defined Pension Benefit | — | 0.00 | 0.00 | 0.00 | — |
| Non Current Prepaid Assets | — | 5.09 Cr | 3.21 Cr | 2.60 Cr | 0.30 Cr |
| Financial Assets | — | 0.00 | 0.00 | 0.00 | — |
| Accumulated Depreciation | — | -60.44 Cr | -35.05 Cr | -26.21 Cr | -17.51 Cr |
| Machinery Furniture Equipment | — | 254.32 Cr | 130.89 Cr | 103.70 Cr | 78.73 Cr |
| Buildings And Improvements | — | 154.40 Cr | 50.48 Cr | 37.65 Cr | 37.45 Cr |
| Land And Improvements | — | 32.05 Cr | 32.55 Cr | 32.55 Cr | 12.06 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Hedging Assets Current | — | 0.00 | 0.52 Cr | 0.11 Cr | 0.24 Cr |
| Restricted Cash | — | 2.67 Cr | 3.55 Cr | 113.17 Cr | 0.86 Cr |
| Other Inventories | — | 1.11 Cr | 1.10 Cr | 1.70 Cr | 0.73 Cr |
| Finished Goods | — | 38.97 Cr | 43.53 Cr | 63.27 Cr | 16.82 Cr |
| Work In Process | — | 71.85 Cr | 58.97 Cr | 43.95 Cr | 26.74 Cr |
| Raw Materials | — | 40.83 Cr | 58.91 Cr | 61.03 Cr | 27.73 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | -0.02 Cr | -0.31 Cr |
| Gross Accounts Receivable | — | 69.85 Cr | 84.40 Cr | 56.62 Cr | 91.06 Cr |
| Cash Equivalents | — | 14.80 Cr | 1.50 Cr | 37.94 Cr | 0.65 Cr |
| Cash Financial | — | 20.51 Cr | 25.86 Cr | 25.08 Cr | 3.83 Cr |
| Non Current Deferred Revenue | — | — | 0.00 | 80000.00 | 0.02 Cr |
| Current Provisions | — | — | 0.33 Cr | 0.18 Cr | 0.11 Cr |
| Total Tax Payable | — | — | 0.21 Cr | 1.02 Cr | 0.39 Cr |
| Taxes Receivable | — | — | 5.54 Cr | — | 0.00 |
| Other Non Current Liabilities | — | — | — | 0.02 Cr | 1.43 Cr |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 2.08 Cr |
| Tradeand Other Payables Non Current | — | — | — | — | 1.41 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Tatva Chintan Pharma Chem Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.